Mija LA, Elkrief A. Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?. Can Oncol Today [Internet]. 2025 Apr. 11 [cited 2025 Apr. 22];2(1):13–17. Available from: https://canadianoncologytoday.com/article/view/2-1-Mija_et_al